Neil Vasan, Director of Breast Cancer Translational Research at NYU Langone Health, shared on X:
“Comprehensive review article by Sara Hurvitz fredhutch on state of the art advances in MBC treatment, published in NEJM.
This is also a timely reference for MDs and scientists and to cite in papers, grants, presentations.”
Title: Advances in Systemic Treatment of Breast Cancer
Authors: Sara Alsterlind Hurvitz
Other articles featuring Neil Vasan on OncoDaily.